BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28864645)

  • 21. Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity.
    Martínez-Costa L; Victoria Ibañez M; Murcia-Bello C; Epifanio I; Verdejo-Gimeno C; Beltrán-Catalán E; Marco-Ventura P
    Can J Ophthalmol; 2013 Oct; 48(5):400-5. PubMed ID: 24093187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
    Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
    Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New trends in early diagnosis of hydroxychloroquine toxic retinopathy.
    Vanderzee G; Tassi D
    Optometry; 2012 May; 83(5):200-7. PubMed ID: 23249122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current screening practice in patients under long-term hydroxychloroquine medication in Taiwan: A nationwide population-based cohort study.
    Yen CY; Lee PH; Yen JC; Chen CC; Hu HY; Tseng PC
    Medicine (Baltimore); 2019 Apr; 98(14):e15122. PubMed ID: 30946384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.
    Melles RB; Marmor MF
    JAMA Ophthalmol; 2014 Dec; 132(12):1453-60. PubMed ID: 25275721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
    Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
    Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VOLUMETRIC SINGLE-LAYER INNER RETINAL ANALYSIS IN PATIENTS WITH HYDROXYCHLOROQUINE TOXICITY.
    Modi YS; Au A; Parikh VS; Ehlers JP; Schachat AP; Singh RP
    Retina; 2016 Oct; 36(10):1941-50. PubMed ID: 27258672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pericentral hydroxychloroquine retinopathy in Korean patients.
    Lee DH; Melles RB; Joe SG; Lee JY; Kim JG; Lee CK; Yoo B; Koo BS; Kim JT; Marmor MF; Yoon YH
    Ophthalmology; 2015 Jun; 122(6):1252-6. PubMed ID: 25712474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
    Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of Microperimetry in Detecting Early Retinal Toxicity of Hydroxychloroquine in Children with Juvenile Systemic Lupus Erythematosus.
    Youssef MM; El-Fayoumi D; Sidky MK; Hegazy AI; Marzouk H; Eltanamly RM
    Ophthalmologica; 2017; 237(3):180-184. PubMed ID: 28297699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case-control study with hydroxychloroquine blood-level analysis.
    Lenfant T; Salah S; Leroux G; Bousquet E; Le Guern V; Chasset F; Francès C; Morel N; Chezel J; Papo T; Cacoub P; Mouthon L; Guettrot-Imbert G; Cohen P; Régent A; Mauget-Faÿsse M; Piette JC; Jallouli M; Costedoat-Chalumeau N;
    Rheumatology (Oxford); 2020 Dec; 59(12):3807-3816. PubMed ID: 32442312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxychloroquine Screening Alert: Change is in the Wind.
    Marmor MF
    Ophthalmic Surg Lasers Imaging Retina; 2017 Feb; 48(2):96-98. PubMed ID: 28195610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential Hyperacuity Perimetry to detect hydroxychloroquine retinal toxicity.
    Anderson C; Pahk P; Blaha GR; Spindel GP; Alster Y; Rafaeli O; Marx JL
    Retina; 2009 Sep; 29(8):1188-92. PubMed ID: 19491724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxychloroquine-related retinal toxicity.
    Ding HJ; Denniston AK; Rao VK; Gordon C
    Rheumatology (Oxford); 2016 Jun; 55(6):957-67. PubMed ID: 26428520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated hydroxychloroquine toxic retinopathy.
    Mohapatra A; Gupta P; Ratra D
    Doc Ophthalmol; 2024 Feb; 148(1):37-45. PubMed ID: 37787933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.
    Tanga L; Centofanti M; Oddone F; Parravano M; Parisi V; Ziccardi L; Kroegler B; Perricone R; Manni G
    Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):715-21. PubMed ID: 21253758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macular sensitivities measured by microperimetry in patients on hydroxychloroquine treatment.
    Eren M; Kucukevcilioglu M; Durukan AH
    Cutan Ocul Toxicol; 2018 Sep; 37(3):275-280. PubMed ID: 29495877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxychloroquine: balancing the need to maintain therapeutic levels with ocular safety: an update.
    Abdulaziz N; Shah AR; McCune WJ
    Curr Opin Rheumatol; 2018 May; 30(3):249-255. PubMed ID: 29517495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxychloroquine retinopathy.
    Yusuf IH; Sharma S; Luqmani R; Downes SM
    Eye (Lond); 2017 Jun; 31(6):828-845. PubMed ID: 28282061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.